It was important to notice that no clinical features, presented by patients, was able to differentially influence analysis of AURKA and AURKB gene expression, showing the importance of aurora kinases as biomarkers in pediatric ALL pathogenesis. This evidence concerns the gene AURKB and acute lymphoblastic leukemia.